As it was previously mentioned, MEK1/2-ERK 1/2 signaling pathway is involved in cell growth and proliferation promotion, so the effects of phosphatidylcholine nanoparticles over breast cancer cell viability were studied. This evidence concerns the gene MAP2K1 and breast cancer.